• DOI:10.1183/09031936.06.00041605
• Corpus ID: 18907596

Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen

@article{Sharma2006DelayedAP,
  title={Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen},
  author={A Sharma and Hui Lin Goh and Nithiananthan Asokananthan and Anthony J Bakker and Graham A. Stewart and Howard W. Mitchell},
  journal={European Respiratory Journal},
  year={2006},
  volume={27},
  pages={20 - 28}
}

• A. Sharma, H. L. Goh, +3 authors H. Mitchell
• Published 1 January 2006
• Biology, Medicine
• European Respiratory Journal

Mucosal trypsin, a protease-activated receptor (PAR) stimulant, may have an endogenous bronchoprotective role on airway smooth muscle. To test this possibility the effects of lumenal trypsin on airway tone in segments of pig bronchus were tested. Bronchial segments from pigs were mounted in an organ chamber containing Kreb's solution. Contractions were assessed from isovolumetric lumen pressure induced by acetylcholine (ACh) or carbachol added to the adventitia. Trypsin, added to the airway lumen (300 µg·mL−1), had no immediate effect on smooth muscle tone but suppressed ACh-induced contractions after 60 min, for at least 3 h. Synthetic activating peptides (AP) for PAR1, PAR2 or PAR3 were without effect, but PAR4 AP caused rapid, weak suppression of contractions. Lumenal thrombin was without effect and did not prevent the effects of trypsin. Effects of trypsin were reduced by Nω-nitro-l-arginine methyl ester but not indomethacin. Trypsin, thrombin and PAR4 AP released prostaglandin E2. Adventitially, trypsin, thrombin and PAR4 AP (but not PAR2 AP) relaxed carbachol-toned airways after <3 min. The findings of this study show that trypsin causes delayed and persistent bronchoprotection by interacting with airway cells accessible from the lumen. The signalling mechanism may involve nitric oxide synthase but not prostanoids or protease-activated receptors.